You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Prevalence of co-morbidities in non-hypertensive, hypertensive and general populations in the various communities

From: A community-based study of hypertension and cardio-metabolic syndrome in semi-urban and rural communities in Nigeria

   MS Hyperglycaemia (≥ 5.6 mmol/l) Abdominal obesity $TC> >6.2 mmol *TG ≥ >1.70 mmol #HDL
Rural NHP 5.1 12.2 20.1 4.7 13.7 33.9
  HP 24.7 23.0 34.4 9.7 22.6 41.3
  GP 10 14.9 28.2 5.9 15.9 35.8
  ORs 6.12 2.15 1.49 2.18 1.83 1.37
  (95% CI) (3.02 - 12.62) (1.15 - 3.99) (0.90 - 2.46) (0.90 - 5.27) 1.01-3.32 (0.84 - 2.22)
  p-value <0.001 0.014 0.12 0.79 0.043 0.20
Semi- urban        
  NHP 8.8 9.6 35.2 5.7 23.1 33.8
  HP 34.7 20.7 57.1 10.8 33.4 27.7
  GP 18.0 13.6 43.7 7.5 26.7 31.7
  Ors (95% CI) 5.52 (3.94 - 7.74) 2.45 (1.69 - 3.57) 2.66 (2.07 - 3.45) 1.99 (1.26 - 3.16) 1.67 (1.26 - 2.21) 0.75 (0.57 - 0.99)
  p-value <0.001 <0.001 <0.001 0.003 <0.001 <0.043
Both communities NHP 7.7 10.4 34.3 5.4 20.4 33.9
  HP 32.8 21.2 55.0 10.6 31.3 30.4
  GP 15.9 13.9 41.1 7.1 23.9 32.7
  Ors (95% CI) 5.82 (4.30 - 7.89) 2.32 (1.69 - 3.18) 2.35 (1.88 - 2.94) 2.06 (1.37 - 3.09) 1.78 (1.38 - 2.28) 0.85 (0.67 -1.09)
  p-value <0.001 <0.001 <0.001 <0.001 <0.001 0.20
  1. Key:$- total cholesterol; *- triglyceride; # - 1.03 mmol/l in males & <1.3 mmol/l in females; NHP non-hypertensive population; HP- population with hypertension; GP- general population; *- p-value: significant